IPO YEAR:
2012
|
Sector:
Health Care
|
Industry:
Biotechnology: In Vitro & In Vivo Diagnostic Substances
|
ADRTSO:
|
MarketCap:
91785227.00
|
Beta:
2.543750724063291
|
52 Week High:
9.8
|
52 Week Low:
0.86
|
52 Week Change:
1.0361990950226243
|
Short Interest:
|
Short Date:
|
Shares Outstanding:
126624110
|
Dividend Rate:
0
|
Dividend Yield:
0.00%
|
ExDividend Date:
|
Latest EPS:
|
Latest EPS Date:
14 Nov 2022
|
Float:
0
|
return on Equity:
-
|
Consensus EPS:
|
Number Of Estimates:
|
EPS Surprise Dollar:
|
Eps Surprise Percent:
|
EBITDA:
N/A
|
ttmEPS:
0
|
Revenue:
$423.264M
|
Gross Profit:
|
Cash:
|
Debt:
|
Institution Percent:
48.50%
|
Revenue Percent:
|
Revenue Per Employee:
|
Insider Percent:
0.70%
|
Return on Assets:
-
|
Return on Capital:
|
Profit Margin:
-
|
Price to Sales:
-
|
Price To Book:
2.74
|
Short Ratio:
3.96
|
PE Ratio:
0
|
Employees:
5
|
1Y Guesstimate
N/A:N/A:N/A
|
|
|
|
|
|
|
|
|
